Deal Announcements

Arzeda Accepts $12 Million Venture Capital Funding

Monday, March 02, 2009 5:42:00 AM PDT | VentureDeal Staff

Seattle, Washington  --  Biotechnology company Arzeda has secured $12 million in its first round of institutional venture capital financing.

Arzeda is developing what it calls "the world's leading computational enzyme design technology" that it says is changing the way people think about biocatalysis.

Investors in the round included OVP Venture Partners and WRF Capital. Proceeds purposes from the funding were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1